NCT04276909View on ClinicalTrials.gov

Feasibility Study of LUM Imaging System for Pancreatic Cancer

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 31, 2026

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Pancreatic Cancer
Interventions
COMBINATION_PRODUCT

LUM Imaging System

LUM015 will be administered at the beginning of surgery. All subjects will have intraoperative imaging using the LUM imaging device.

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

Sponsors

Lead Sponsor

Lumicell, Inc.
All Listed Sponsors
lead

Lumicell, Inc.

INDUSTRY